Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MURA Mural Oncology

未开盘 09-23 16:00:00 EDT

2.09

+0.02

+0.97%

盘后2.09

+0.000.00%

19:55 EDT

最高2.10	最低2.07	成交量22.62万
今开2.07	昨收2.07	日振幅1.45%
总市值3,621万	流通市值2,935万	总股本1,732万
成交额47.22万	换手率1.61%	流通股本1,404万
市净率0.62	ROE-111.75%	每股收益-8.59
52周最高4.74	52周最低0.9500	市盈率-0.24
股息0.00	股息收益率0.00	ROA-52.60%

北京优虎网络科技有限公司

{"stockData":{"symbol":"MURA","market":"US","secType":"STK","nameCN":"Mural Oncology","latestPrice":2.09,"timestamp":1758657600000,"preClose":2.07,"halted":0,"volume":226205,"hourTrading":{"tag":"盘后","latestPrice":2.09,"preClose":2.09,"latestTime":"19:55 EDT","volume":539,"amount":1126.0009,"timestamp":1758671742847},"delay":0,"floatShares":14041645,"shares":17324771,"eps":-8.587714,"marketStatus":"未开盘","change":0.02,"latestTime":"09-23 16:00:00 EDT","open":2.07,"high":2.1,"low":2.07,"amount":472151.181796,"amplitude":0.014493,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.587714,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1758700800000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":2.07,"preHourTrading":{"tag":"盘前","latestPrice":2.08,"preClose":2.07,"latestTime":"09:29 EDT","volume":66,"amount":137.28,"timestamp":1758634199028},"postHourTrading":{"tag":"盘后","latestPrice":2.09,"preClose":2.09,"latestTime":"19:55 EDT","volume":539,"amount":1126.0009,"timestamp":1758671742847},"volumeRatio":1.199436,"impliedVol":1.1662,"impliedVolPercentile":0.78},"requestUrl":"/m/hq/s/MURA","defaultTab":"news","newsList":[{"id":"2558021975","title":"Mural Oncology Plc2025财年第二财季实现净利润-47.98百万美元，同比减少52.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558021975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558021975?lang=zh_cn&edition=full","pubTime":"2025-08-10 00:01","pubTimestamp":1754755296,"startTime":"0","endTime":"0","summary":"8月10日，Mural Oncology Plc公布财报，公告显示公司2025财年第二财季净利润为-47.98百万美元，同比减少52.03%；其中营业收入为0.00美元，每股基本收益为-2.78美元。从资产负债表来看，Mural Oncology Plc总负债28.77百万美元，其中短期债务5.01百万美元，资产负债比为3.05，流动比率为2.87。机构评级：截至2025年8月10日，当前有1家机构对Mural Oncology Plc目标价做出预测，其中目标均价为6.00美元，其中最低目标价为6.00美元，最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000335a6dcb85c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810000335a6dcb85c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA"],"gpt_icon":0},{"id":"2557598974","title":"Mural Oncology Plc盘中异动 下午盘急速跳水5.06%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557598974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557598974?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:38","pubTimestamp":1754588313,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时38分，Mural Oncology Plc股票出现波动，股价急速下挫5.06%。截至发稿，该股报1.69美元/股，成交量17.5013万股，换手率1.01%，振幅5.77%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.27%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808013833973a0d5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808013833973a0d5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2557397524","title":"Mural Oncology Plc盘中异动 快速下跌6.49%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557397524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557397524?lang=zh_cn&edition=full","pubTime":"2025-08-05 21:50","pubTimestamp":1754401806,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日21时50分，Mural Oncology Plc股票出现异动，股价急速下跌6.49%。截至发稿，该股报1.73美元/股，成交量6.9464万股，换手率0.40%，振幅5.41%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为3.08%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080521500794d167fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080521500794d167fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2556913387","title":"Mural Oncology Plc盘中异动 早盘大幅跳水5.17%报2.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556913387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556913387?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:39","pubTimestamp":1754314761,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时39分，Mural Oncology Plc股票出现波动，股价大幅跳水5.17%。截至发稿，该股报2.20美元/股，成交量6.4264万股，换手率0.37%，振幅2.59%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.84%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042139219732f414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042139219732f414&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2556810913","title":"Mural Oncology Plc盘中异动 股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556810913","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556810913?lang=zh_cn&edition=full","pubTime":"2025-08-02 00:29","pubTimestamp":1754065788,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日00时29分，Mural Oncology Plc股票出现波动，股价大幅拉升5.33%。截至发稿，该股报2.37美元/股，成交量11.7888万股，换手率0.68%，振幅3.56%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.43%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802002948972d4b24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802002948972d4b24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2551138479","title":"Mural Oncology Plc盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551138479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551138479?lang=zh_cn&edition=full","pubTime":"2025-07-15 01:49","pubTimestamp":1752515360,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日01时49分，Mural Oncology Plc股票出现异动，股价急速拉升5.36%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.68%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715014920954262a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715014920954262a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2549554343","title":"Mural Oncology Plc盘中异动 下午盘股价大跌5.01%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549554343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549554343?lang=zh_cn&edition=full","pubTime":"2025-07-08 01:29","pubTimestamp":1751909381,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日01时29分，Mural Oncology Plc股票出现异动，股价急速跳水5.01%。截至发稿，该股报2.45美元/股，成交量3.2165万股，换手率0.19%，振幅4.26%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.66%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708012941a69b6207&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708012941a69b6207&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2536837601","title":"Mural Oncology Plc5月16日成交额为57.65万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536837601","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536837601?lang=zh_cn&edition=full","pubTime":"2025-05-17 10:37","pubTimestamp":1747449479,"startTime":"0","endTime":"0","summary":"美东时间2025年5月16日，Mural Oncology Plc成交额为57.65万美元，成交额较昨日增加89.52%，当日成交量为22.20万股。Mural Oncology Plc于2025年5月16日涨4.74%，报2.65美元，该股过去5个交易日涨0.76%，年初至今跌17.7%，过去60日跌37.2%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-16|57.65万|89.52%|22.20万|#|2025-05-15|30.42万|53.45%|12.17万|#|2025-05-14|19.82万|-49.74%|7.60万|#|2025-05-13|39.44万|-51.85%|14.77万|#|2025-05-12|81.91万|16.68%|31.31万|Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517103808a6e252f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517103808a6e252f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2535300558","title":"Mural Oncology Plc5月14日成交额为19.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535300558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535300558?lang=zh_cn&edition=full","pubTime":"2025-05-15 10:35","pubTimestamp":1747276545,"startTime":"0","endTime":"0","summary":"美东时间2025年5月14日，Mural Oncology Plc成交额为19.82万美元，成交额较昨日减少49.74%，当日成交量为7.60万股。Mural Oncology Plc于2025年5月14日跌3.76%，报2.56美元，该股过去5个交易日涨1.19%，年初至今跌20.5%，过去60日跌40.6%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-14|19.82万|-49.74%|7.60万|#|2025-05-13|39.44万|-51.85%|14.77万|#|2025-05-12|81.91万|16.68%|31.31万|#|2025-05-09|70.20万|-38.51%|27.00万|#|2025-05-08|114.16万|208.82%|44.87万|Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515103550a6dfba6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515103550a6dfba6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2535752983","title":"Mural Oncology Plc5月12日成交额为81.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535752983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535752983?lang=zh_cn&edition=full","pubTime":"2025-05-13 10:30","pubTimestamp":1747103445,"startTime":"0","endTime":"0","summary":"美东时间2025年5月12日，Mural Oncology Plc成交额为81.91万美元，成交额较昨日增加16.68%，当日成交量为31.31万股。Mural Oncology Plc于2025年5月12日涨0.38%，报2.64美元，该股过去5个交易日涨3.94%，年初至今跌18.01%，过去60日跌38.03%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-12|81.91万|16.68%|31.31万|#|2025-05-09|70.20万|-38.51%|27.00万|#|2025-05-08|114.16万|208.82%|44.87万|#|2025-05-07|36.97万|-67.36%|14.61万|#|2025-05-06|113.27万|20.51%|44.85万|Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513103046a6dcebba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513103046a6dcebba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2534211907","title":"Mural Oncology Plc5月8日成交额为114.16万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534211907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534211907?lang=zh_cn&edition=full","pubTime":"2025-05-09 10:15","pubTimestamp":1746756902,"startTime":"0","endTime":"0","summary":"美东时间2025年5月8日，Mural Oncology Plc成交额为114.16万美元，成交额较昨日增加208.82%，当日成交量为44.87万股。Mural Oncology Plc于2025年5月8日涨2.37%，报2.59美元，该股过去5个交易日跌0.77%，年初至今跌19.57%，过去60日跌37.89%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-08|114.16万|208.82%|44.87万|#|2025-05-07|36.97万|-67.36%|14.61万|#|2025-05-06|113.27万|20.51%|44.85万|#|2025-05-05|93.99万|0.63%|36.68万|#|2025-05-02|93.40万|-7.82%|35.64万|Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509101508a6d87103&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509101508a6d87103&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2532015804","title":"Mural Oncology Plc5月2日成交额为93.40万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532015804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532015804?lang=zh_cn&edition=full","pubTime":"2025-05-03 10:08","pubTimestamp":1746238084,"startTime":"0","endTime":"0","summary":"美东时间2025年5月2日，Mural Oncology Plc成交额为93.40万美元，成交额较昨日减少7.82%，当日成交量为35.64万股。Mural Oncology Plc于2025年5月2日涨1.15%，报2.64美元，该股过去5个交易日涨1.54%，年初至今跌18.01%，过去60日跌35.14%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-02|93.40万|-7.82%|35.64万|#|2025-05-01|101.32万|9.55%|38.98万|#|2025-04-30|92.49万|-12.24%|35.17万|#|2025-04-29|105.38万|-11.41%|40.34万|#|2025-04-28|118.95万|4.91%|45.50万|Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503100808a47087cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503100808a47087cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2532010192","title":"Mural Oncology Plc4月30日成交额为92.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532010192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532010192?lang=zh_cn&edition=full","pubTime":"2025-05-01 10:08","pubTimestamp":1746065315,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，Mural Oncology Plc成交额为92.49万美元，成交额较昨日减少12.24%，当日成交量为35.17万股。Mural Oncology Plc于2025年4月30日涨0.38%，报2.63美元，该股过去5个交易日跌5.05%，年初至今跌18.32%，过去60日跌28.14%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501100844a6cf8e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501100844a6cf8e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2531728073","title":"Mural Oncology Plc4月29日成交额为105.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531728073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531728073?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:07","pubTimestamp":1745978824,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，Mural Oncology Plc成交额为105.38万美元，成交额较昨日减少11.41%，当日成交量为40.34万股。Mural Oncology Plc于2025年4月29日涨0.38%，报2.62美元，该股过去5个交易日跌3.68%，年初至今跌18.63%，过去60日跌30.13%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430100712a46cfd22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430100712a46cfd22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2531921286","title":"Mural Oncology Plc4月28日成交额为118.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531921286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531921286?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:06","pubTimestamp":1745892370,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，Mural Oncology Plc成交额为118.95万美元，成交额较昨日增加4.91%，当日成交量为45.50万股。Mural Oncology Plc于2025年4月28日涨0.38%，报2.61美元，该股过去5个交易日跌2.97%，年初至今跌18.94%，过去60日跌30.77%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429100614a6cc7eca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429100614a6cc7eca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2530111313","title":"Mural Oncology Plc4月25日成交额为113.38万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530111313","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530111313?lang=zh_cn&edition=full","pubTime":"2025-04-26 10:05","pubTimestamp":1745633136,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，Mural Oncology Plc成交额为113.38万美元，成交额较昨日减少45.98%，当日成交量为43.78万股。Mural Oncology Plc于2025年4月25日跌1.52%，报2.6美元，该股过去5个交易日跌3.7%，年初至今跌19.25%，过去60日跌30.11%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MURA"],"gpt_icon":0},{"id":"2529059087","title":"Mural Oncology Plc4月22日成交额为321.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529059087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529059087?lang=zh_cn&edition=full","pubTime":"2025-04-23 10:04","pubTimestamp":1745373850,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日，Mural Oncology Plc成交额为321.75万美元，成交额较昨日减少11.96%，当日成交量为118.25万股。Mural Oncology Plc于2025年4月22日涨1.12%，报2.72美元，该股过去5个交易日涨164.08%，年初至今跌15.53%，过去60日跌31.14%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423100421a6c486f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423100421a6c486f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":0},{"id":"2529838213","title":"Mural Oncology Plc盘中异动 股价大跌5.19%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529838213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529838213?lang=zh_cn&edition=full","pubTime":"2025-04-21 23:57","pubTimestamp":1745251063,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日23时57分，Mural Oncology Plc股票出现异动，股价大幅下跌5.19%。截至发稿，该股报2.56美元/股，成交量79.95万股，换手率4.64%，振幅6.67%。Mural Oncology Plc股票所在的生物技术行业中，整体跌幅为0.22%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421235743a4614487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421235743a4614487&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":1},{"id":"2528470044","title":"Mural Oncology Plc4月17日成交额为1520.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528470044","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528470044?lang=zh_cn&edition=full","pubTime":"2025-04-18 10:07","pubTimestamp":1744942055,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，Mural Oncology Plc成交额为1520.35万美元，成交额较昨日减少23.23%，当日成交量为576.50万股。Mural Oncology Plc于2025年4月17日涨11.57%，报2.7美元，该股过去5个交易日涨171.36%，年初至今跌16.15%，过去60日跌31.65%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100744a45d4a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418100744a45d4a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":1},{"id":"2528743925","title":"Mural Oncology Plc盘中异动 早盘股价大涨5.58%报2.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528743925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528743925?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:41","pubTimestamp":1744897301,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时41分，Mural Oncology Plc股票出现异动，股价大幅拉升5.58%。截至发稿，该股报2.56美元/股，成交量69.6749万股，换手率4.04%，振幅3.30%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.43%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041721414294d8d467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041721414294d8d467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MURA","BK4139"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.muraloncology.com","stockEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":0.0048},{"period":"3month","weight":-0.1504},{"period":"6month","weight":0.5481},{"period":"1year","weight":-0.3569},{"period":"ytd","weight":-0.3509}],"compareEarnings":[{"period":"1week","weight":0.0049},{"period":"1month","weight":0.0277},{"period":"3month","weight":0.0924},{"period":"6month","weight":0.1695},{"period":"1year","weight":0.1642},{"period":"ytd","weight":0.1316}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mural Oncology plc是一家爱尔兰注册公众有限公司，于2017年5月成立，是一家私人股份有限公司，2023年8月21日，该公司重新注册为公共有限公司，并更名为Mural Oncology plc。该公司是一家临床阶段的肿瘤学公司，专注于发现和开发可能有意义地改善癌症患者生活的免疫疗法。通过利用公司在免疫细胞调节和蛋白质工程方面的核心竞争力，该公司开发了一系列新型的研究性细胞因子疗法，旨在解决多种癌症患者未满足需求的领域。该公司的主要候选产品nemvaleukin alfa（“nemvaleukin”）是一种研究性、工程化的白细胞介素-2（“IL-2”）细胞因子，旨在捕获和扩大大剂量重组人IL-2（“rhIL-2”）的治疗益处，同时减轻其标志性毒性。","exchange":"NASDAQ","name":"Mural Oncology","nameEN":"Mural Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mural Oncology(MURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mural Oncology,MURA,Mural Oncology股票,Mural Oncology股票老虎,Mural Oncology股票老虎国际,Mural Oncology行情,Mural Oncology股票行情,Mural Oncology股价,Mural Oncology股市,Mural Oncology股票价格,Mural Oncology股票交易,Mural Oncology股票购买,Mural Oncology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mural Oncology(MURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mural Oncology(MURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}